0
Your cart

Your cart is empty

Browse All Departments
  • All Departments
Price
  • R500 - R1,000 (1)
  • R1,000 - R2,500 (2)
  • R2,500 - R5,000 (2)
  • -
Status
Brand

Showing 1 - 5 of 5 matches in All Departments

Leading Pharmaceutical Innovation - How to Win the Life Science Race (Hardcover, 3rd ed. 2018): Oliver Gassmann, Alexander... Leading Pharmaceutical Innovation - How to Win the Life Science Race (Hardcover, 3rd ed. 2018)
Oliver Gassmann, Alexander Schuhmacher, Max Von Zedtwitz, Gerrit Reepmeyer
R2,637 Discovery Miles 26 370 Ships in 12 - 19 working days

Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.

Leading Pharmaceutical Innovation - Trends and Drivers for Growth in the Pharmaceutical Industry (Hardcover, 2nd ed. 2008):... Leading Pharmaceutical Innovation - Trends and Drivers for Growth in the Pharmaceutical Industry (Hardcover, 2nd ed. 2008)
Oliver Gassmann, Gerrit Reepmeyer, Maximilian Von Zedtwitz
R1,526 Discovery Miles 15 260 Ships in 10 - 15 working days

Pharmaceutical giants have doubled their investments in drug development in the past decade only to see new drug approvals remain constant. This book investigates and highlights a set of proactive strategies aimed at generating sustainable competitive advantage based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of cooperation and internationalization, such as open innovation in the early phases of R&D. Our findings are illustrated by cases from Europe, the US, and Asia.

UnCommoditized - Uncommon Ideas for Commoditized Markets (Hardcover): Saikat Dey, Gerrit Reepmeyer UnCommoditized - Uncommon Ideas for Commoditized Markets (Hardcover)
Saikat Dey, Gerrit Reepmeyer
R725 Discovery Miles 7 250 Ships in 12 - 19 working days
Risk-sharing in the Pharmaceutical Industry - The Case of Out-licensing (Paperback, 2006 ed.): Gerrit Reepmeyer Risk-sharing in the Pharmaceutical Industry - The Case of Out-licensing (Paperback, 2006 ed.)
Gerrit Reepmeyer
R2,975 Discovery Miles 29 750 Ships in 10 - 15 working days

The productivity in pharmaceutical research and development faces intense pres sure. R&D expenditures of the major US and European companies have topped US$ 33 billion in 2003 compared to around US$ 13 billion just a decade ago. At the same time, the number of new drug approvals has dropped from 53 in 1996 to only 35 in 2003. Moreover, the protraction of clinical trials has significantly reduced the effective time of patent protection. The consequences are devastating. Monopoly profits have started to decline and the average costs per new drug have reached a re cord level of close to US$ 1 billion today. As a result, any failure of a new sub stance in the R&D process can lead to considerable losses, and the risks of introduc ing a new drug to the market have grown tremendously. Particularly if a company is highly dependent on just a handful of mega-selling blockbuster drugs, the risks can be even greater. For example, Pfizer generated about 90% of its worldwide revenues in 2002 with just 8 products. Any shortfall of a promising late-stage drug candidate would have left Pfizer with a gaping hole in its product portfolio. In order to deal with these risks, many pharmaceutical companies have started to organize their R&D in partnership. In fact, more than 600 alliances in pharmaceutical R&D are signed every year."

Leading Pharmaceutical Innovation - How to Win the Life Science Race (Paperback, Softcover reprint of the original 3rd ed.... Leading Pharmaceutical Innovation - How to Win the Life Science Race (Paperback, Softcover reprint of the original 3rd ed. 2018)
Oliver Gassmann, Alexander Schuhmacher, Max Von Zedtwitz, Gerrit Reepmeyer
R1,767 Discovery Miles 17 670 Ships in 10 - 15 working days

Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.

Free Delivery
Pinterest Twitter Facebook Google+
You may like...
Christianity, Islam, and the One True…
Steven Colborne Hardcover R591 Discovery Miles 5 910
Chesley's Hypertensive Disorders in…
Robert N Taylor, Kirk P. Conrad, … Paperback R4,789 Discovery Miles 47 890
Polyester-Based Biocomposites
Senthilkumar Krishnasamy, Chandrasekar Muthukumar, … Paperback R1,830 Discovery Miles 18 300
Reproductive Consequences of Pediatric…
Peter A. Lee Hardcover R1,793 Discovery Miles 17 930
Protective Armor Engineering Design
Magdi El Messiry Paperback R2,622 Discovery Miles 26 220
Cardinal - The Rise and Fall of George…
Louise Milligan Paperback  (1)
R846 R652 Discovery Miles 6 520
First Aid 101 - How To Do First Aid Step…
Paolo Jose De Luna, Howexpert Press Paperback R505 Discovery Miles 5 050
Behind Prison Walls - Unlocking a Safer…
Edwin Cameron, Rebecca Gore, … Paperback R350 R310 Discovery Miles 3 100
Immunology, Inflammation and Diseases of…
Darlene A. Dartt, Reza Dana, … Paperback R3,050 Discovery Miles 30 500
Duelling Dragons
Sean Rice, Naomi Cornock Hardcover R670 Discovery Miles 6 700

 

Partners